SAJJADI, ELHAM
SAJJADI, ELHAM
Dipartimento di Oncologia ed Emato-Oncologia
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
2022 L. Nicosia, A.C. Bozzini, S. Penco, C. Trentin, M. Pizzamiglio, M. Lazzeroni, G. Lissidini, P. Veronesi, G. Farante, S. Frassoni, V. Bagnardi, C. Fodor, N. Fusco, E. Sajjadi, E. Cassano, F. Pesapane
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
Biomarkers for precision immunotherapy in the metastatic setting : hope or reality?
2020 E. Sajjadi, K. Venetis, C. Scatena, N. Fusco
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
2022 E. Sajjadi, K. Venetis, M. Noale, H.A. Azim, C. Blundo, G. Bonizzi, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, M. Barberis, P. Veronesi, V.E. Galimberti, G. Viale, N. Fusco, F.A. Peccatori, E. Guerini-Rocco
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
2021 K. Venetis, R. Piciotti, E. Sajjadi, M. Invernizzi, S. Morganti, C. Criscitiello, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022 C. Corti, K. Venetis, E. Sajjadi, L. Zattoni, G. Curigliano, N. Fusco
Cellular immunotherapy in breast cancer: The quest for consistent biomarkers
2020 K. Venetis, M. Invernizzi, E. Sajjadi, G. Curigliano, N. Fusco
Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients
2020 N. Fusco, V. Vaira, I. Righi, E. Sajjadi, K. Venetis, G. Lopez, M. Castellani, L. Rosso, M. Nosotti, M. Clerici, S. Ferrero
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
2021 E. Sajjadi, K. Venetis, R. Piciotti, D. Gambini, C. Blundo, L. Runza, S. Ferrero, E. Guerini-Rocco, N. Fusco
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality
2021 M. Salati, K. Venetis, M. Fassan, U. Malapelle, F. Pagni, E. Sajjadi, N. Fusco, M. Ghidini
Determination of Mismatch repair status in human cancer and its clinical significance : does one size fit all?
2019 C. Corti, E. Sajjadi, N. Fusco
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
2021 C. Blundo, M. Giroda, N. Fusco, E. Sajjadi, K. Venetis, M.C. Leonardi, E. Vicini, L. Despini, C.F. Rossi, L. Runza, M.S. Sfondrini, R. Piciotti, E. Di Loreto, G. Scarfone, E. Guerini-Rocco, G. Viale, P. Veronesi, B. Buonomo, F.A. Peccatori, V.E. Galimberti
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
2022 A. de Sire, L. Lippi, K. Venetis, S. Morganti, E. Sajjadi, C. Curci, A. Ammendolia, C. Criscitiello, N. Fusco, M. Invernizzi
Exercise therapy to reduce breast cancer fatigue: Results from the EXPECT study
2021 M. Invernizzi, A. de Sire, E. Sajjadi, K. Venetis, A. Gennari, N. Fusco
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022 K. Venetis, E. Crimini, E. Sajjadi, C. Corti, E. Guerini-Rocco, G. Viale, G. Curigliano, C. Criscitiello, N. Fusco
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer : Between Biomarkers and Novel Cell-Based Approaches
2021 M. Ghidini, A. Petrillo, A. Botticelli, D. Trapani, A. Parisi, A. La Salvia, E. Sajjadi, R. Piciotti, N. Fusco, S. Khakoo
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology
2021 C. Criscitiello, E. Guerini-Rocco, G. Viale, C. Fumagalli, E. Sajjadi, K. Venetis, R. Piciotti, M. Invernizzi, U. Malapelle, N. Fusco
Impact of Rehabilitation on Breast Cancer Related Fatigue : A Pilot Study
2020 M. Invernizzi, A. de Sire, L. Lippi, K. Venetis, E. Sajjadi, F. Gimigliano, A. Gennari, C. Criscitiello, C. Cisari, N. Fusco
Integrated analysis of mismatch repair, PD-L1, and immune microenvironment status in pregnancy-associated breast cancers
2019 N. Fusco, E. Guerini-Rocco, B. Buonomo, R. Croci, C. Fumagalli, G. Lopez, G.A. Croci, L. Runza, E. Sajjadi, C. Blundo, L. Despini, M. Giroda, V.E. Galimberti, P. Veronesi, M. Barberis, S. Ferrero, G. Scarfone, S. Bosari, G. Viale, F. Peccatori